Outlook Therapeutics, Inc. (OTLK)
2.165
+0.18
(+9.34%)
USD |
NASDAQ |
Dec 15, 16:00
2.17
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics EPS Diluted (Quarterly): -0.5453 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.15M |
| Revenue (Quarterly) | 1.505M |
| Total Expenses (Quarterly) | 21.66M |
| Enterprise Value | 113.75M |
| Gross Profit Margin (Quarterly) | 68.83% |
| Profit Margin (Quarterly) | -1.34K% |
| Earnings Yield | -50.42% |
| Normalized Earnings Yield | -101.45 |